Dr Reddy's Lab to enter Japanese market through a partner

Last Updated: Tuesday, May 12, 2015, 19:37

Pharmaceutical major Dr Reddy's Laboratories Tuesday said it has plans to enter Japanese market through partnerships for specific products.

Dr Reddy's Q4 net rises 8% to Rs 519 crore

Last Updated: Tuesday, May 12, 2015, 16:02

The company had posted a net profit of Rs 481.60 crore for the corresponding period of previous fiscal, it said in a filing to the BSE.

Dr Reddy's sees India sales growing 20% on new product launches

Last Updated: Friday, April 10, 2015, 11:06

Dr Reddy`s Laboratories Ltd, India`s second-largest drugmaker, expects domestic sales to grow nearly 20 percent this financial year, helped by the launch of nearly two dozen products, a senior executive said.

Dr Reddy's to buy UCB's select brands for Rs 800 crore

Last Updated: Wednesday, April 1, 2015, 14:43

"The acquired business is being sold on a slump sale basis. The revenues of the acquired business is approximately Rs 150 crore for the calendar year 2014," it added.

Dr Reddy's shares up on Hepatitis C drug launch plan

Last Updated: Tuesday, March 24, 2015, 19:08

Shares of Dr Reddy's Laboratories on Tuesday settled with gains of nearly 2 percent after the firm said it is planning to launch Hepatitis C drug in the country, following which its market capitalisation rose Rs 1,000 crore.

Dr Reddy's to launch Hepatitis C drug in India

Last Updated: Monday, March 23, 2015, 17:50

Dr Reddy's Laboratories today entered into an agreement with Hetero to distribute and market generic version of US-firm Gilead Sciences' Hepatitis C drug under the brand 'Resof' in India.

Zee launches entertainment channel in Indonesia

Last Updated: Monday, March 23, 2015, 13:59

The new channel would feature popular Indian serials localised for the Indonesian audience, the Essel Group firm on Monday said in a statement.

CAG blames I-T Dept for Rs 1348 cr tax loss in pharma sector

Last Updated: Friday, March 20, 2015, 19:28

Coming down heavily on the I-T Department, CAG has said non-compliance of procedures for giving incentives to pharmaceutical firms, including Ranbaxy, Dr Reddy's and Piramal, resulted Rs 1,348.44 crore loss to the exchequer.

'Dr Reddy's in talks to buy UCB India business for $135 million'

Last Updated: Tuesday, March 10, 2015, 19:34

Drugmaker Dr Reddy`s Laboratories Ltd is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA for about $135 million, said a person with direct knowledge of the matter.

ZEE completes 20 years in Europe

Last Updated: Tuesday, March 10, 2015, 09:07

After its launch in India in 1992, Zee TV came to the UK in March 1995 to meet the entertainment demands of the South Asian community.

Attorney Generals of Texas, California probe DRL's drug pricing mechanism

Last Updated: Wednesday, February 25, 2015, 10:50

Attorney Generals of Texas and California have separately sought information on pricing of some drugs sold by Dr Reddy's Laboratories in the US, according to the latest filing for the drug maker with SEC.

Medanta Group to invest Rs 1,500 crore in next five years

Last Updated: Sunday, February 8, 2015, 17:25

"We have a plan to open five hospitals in next five years with an investment Rs 1,500 crore," Medanta Group Founder Chairman Dr Naresh Trehan told reporters after inauguration of their super-speciality hospital here.